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Abstract
The FAM123 gene family comprises three members, FAM123A, the tumor suppressor
WTX(FAM123B) and FAM123C. WTX is required for normal development and causally
contributes to human disease, in part through its regulation of β-catenin-dependent WNT
signaling. The roles of FAM123A and FAM123C in signaling, cell behavior and human disease
remain less understood. We defined and compared the protein-protein interaction networks for
each member of the FAM123 family by affinity purification and mass spectrometry. Protein
localization and functional studies suggest that the FAM123 family members have conserved and
divergent cellular roles. In contrast to WTX and FAM123C, we found that microtubule-associated
proteins were enriched in the FAM123A protein interaction network. FAM123A interacted with
and tracked dynamic microtubules in a plus-end direction. Domain interaction experiments
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revealed a ‘SKIP’ amino acid motif in FAM123A that mediated interaction with the microtubule
tip tracking proteins EB1 and EB3, and therefore with microtubules. Cells depleted of FAM123A
showed compartment-specific effects on microtubule dynamics, increased actomyosin
contractility, larger focal adhesions and decreased cell migration. These effects required binding
of FAM123A to and inhibition of the guanine nucleotide exchange factor ARHGEF2, a
microtubule-associated activator of RhoA. Together, these data suggest that the ‘family-unique’
SKIP motif enables FAM123A to bind EB proteins, localize to microtubules and coordinate
microtubule dynamics and actomyosin contractility.
Introduction
The FAM123 gene family comprises three members: FAM123A, which is also known as
AMER2; FAM123B, which is also known as WTX, AMER1 and OSCS; and FAM123C.
The founding member, FAM123B (hereafter referred to as WTX) plays fundamental roles in
normal development and human disease. Mutations in WTX contribute to various diseases,
such as Wilms tumor, a pediatric kidney cancer (1, 2), and osteopathia striata congenita with
cranial sclerosis (OSCS), an X-linked developmental disorder that causes bone-related
defects in females (3) and is lethal in males, often at embryonic or neonatal developmental
stages. Mice lacking WTX display various developmental abnormalities in tissues of
mesenchymal origin, such as increased bone mass and decreased adipose tissue (4). Cellular
and molecular analyses of these tissues indicate a critical role for WTX in regulating cell
differentiation programs in mesenchymal progenitors.
Mass spectrometry-based proteomic dissection of WTX protein complexes has revealed
several core components of the β-catenin-dependent WNT signal transduction pathway,
including β-catenin (encoded by CTNNB1), βTrCP2 (encoded by FBXW11) and
adenomatous polyposis coli (APC) (5, 6). Subsequent functional studies in various cells and
organisms demonstrated that WTX inhibits WNT pathway activity (4, 5, 7). In vitro studies
and cell-based assays suggest that WTX promotes β-catenin ubiquitination and subsequent
proteasomal degradation, perhaps by serving as a membrane-bound scaffold for the β-
catenin phosphorylation complex (5-8).
Of the FAM123 family members, WTX and FAM123A share greatest homology,
particularly in their N-termini (6, 9, 10). Two conserved functional domains in WTX and
FAM123A have been identified and characterized (6, 11). First, both proteins share an N-
terminal phosphatidylinositol(4,5)-bisphosphate-binding domain that localizes these proteins
to the plasma membrane and is required for WTX- and FAM123A-mediated inhibition of
WNT signal transduction. Second, WTX and FAM123A directly bind to APC and regulate
its subcellular distribution, recruiting it from the microtubule tip complex to the plasma
membrane. Although the functional consequences of this redistribution are not completely
understood, the role for APC in microtubule stabilization and maintenance of cell-cell
junctions suggests that WTX and FAM123A may influence directional cell migration and
polarity (6). Whether the more distantly related family member FAM123C also regulates
WNT signaling, localizes to the plasma membrane or binds APC remains unknown.
In contrast to WTX, the cellular, developmental and disease contributions of FAM123A and
FAM123C remain less understood. Thus, we defined and compared the protein-protein
interaction networks for each member in the FAM123 family. Functional annotation of the
resulting protein interaction network and comparative protein dynamic studies supports both
conserved and divergent functions for the FAM123 family members. Here we report a
‘family-unique’ function for FAM123A in controlling communication between the
microtubule and actomyosin cytoskeletal networks. We found that FAM123A binds the
microtubule plus-end tracking proteins EB1 and EB3, moves on microtubules, controls
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microtubule dynamics, actomyosin organization and cell migration. We present a model
wherein FAM123A binds to and inhibits GEF-H1 (encoded by ARHGEF2) to decrease
actomyosin contractility.
Results
Comparative proteomics of the WTX family reveals shared and unique interactions
To provide insight into the cellular functions of FAM123A and FAM123C, we defined their
protein interaction networks by shot-gun liquid chromatography–tandem-mass spectrometry
of affinity purified protein complexes. Integration of the resulting protein interaction
networks with a previously defined WTX protein interaction network revealed shared and
unique protein-protein interactions (Fig. 1A and Table S1). Consistent with the homology
relationships within the family, FAM123A and WTX shared several common interacting
proteins; in contrast, the FAM123C protein interaction network was distinct (Fig. 1B and
Table S1).
Because of their homology, overlapping protein interaction networks and shared function as
inhibitors of WNT signaling, protein interactions from the WTX and FAM123A networks
were validated. FAM123A or WTX protein complexes were isolated by streptavidin affinity
purification from HEK293T cells and associated endogenous proteins were detected by
Western blot. Whereas both WTX and FAM123A proteins associated with APC and
βTrCP1 (encoded by BTRC) and βTrCP2 (encoded by FBXW11), WTX specifically bound
β-catenin, confirming the proteomic data (Fig. 1C). These results strengthen models in
which WTX and FAM123A functionally regulate β-catenin-dependent WNT signaling at
the level of the destruction complex, most likely through interactions with APC, βTrCP1 or
βTrCP2.
We chose to further investigate the enrichment of microtubule associated proteins in the
FAM123A protein interaction network (Fig. 1A, green nodes), such as EB1 (encoded by
MAPRE1), an obligate component of the microtubule plus-end tip tracking protein complex
(12-14). Western blot analysis of affinity purified protein complexes revealed an interaction
between FAM123A and endogenous EB1, but not between WTX and EB1 (Fig. 1C).
Additionally, several other proteins in the FAM123A network bind to the microtubule
cytoskeleton: the microtubule affinity regulating kinases MARK2 and MARK3, GEF-H1,
EB3 (encoded by MAPRE3), ACF7 (encoded by MACF1), CLASP2 and APC (15-20)
(Table S1). By affinity purification and mass spectrometry, these proteins are frequently
observed FAM123A interacting proteins, and are largely absent from the WTX protein
interaction network (Fig. 1A).
FAM123A moves on growing microtubules
WTX and FAM123A, but not FAM123C, localize predominantly to the cytoplasmic face of
the plasma membrane through interactions with phospholipids (Fig. S1) (6). Given the
relative enrichment of microtubule-associated proteins in the FAM123A protein interaction
network, we hypothesized that a pool of FAM123A might localize to and move on
microtubules. Imaging of Venus-FAM123A or Venus-WTX in live HT1080 human sarcoma
cells (Fig. 1D) indicated that both proteins exhibited mainly membranous distribution,
seemed to be enriched at cell ruffles and induced cell death when overexpressed. In cells
expressing low to moderate amounts FAM123A (movie S1), but not WTX (movie S2),
localized to filamentous structures resembling microtubules. This localization pattern was
often polarized with respect to the direction of cell movement; of 142 cells with low to
moderate expression of FAM123A, 94 cells showed FAM123A decorating filamentous
structures polarized in the direction of cell movement. Co-localization of FAM123A and α-
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tubulin confirmed the microtubule localization suggested by live cell imaging (Fig. 1E),
which was abolished by the addition of the microtubule destabilizing drug nocodazole. By
high resolution live cell imaging, EGFP-FAM123A predominantly moves on segments of
microtubules and was also observed as dots that moved on linear trajectories from the cell
body toward the cell periphery (movie S3). Thus, both comparative proteomics and live cell
imaging demonstrate that FAM123A and not WTX associates with and moves on
microtubules.
FAM123A interacts with APC and EB1 through distinct domains
Mass spectrometry and Western blot analysis revealed that FAM123A associated with the
plus-end tracking protein EB1 (Fig. 1A and Fig. 1C). Stably expressed HA-tagged
FAM123A was detected in protein complexes isolated by immunopurification of
endogenous EB1 (Fig. 2A). To demonstrate the interaction between the endogenous
proteins, we generated an antibody against FAM123A and confirmed its specificity with two
non-overlapping FAM123A-specific siRNAs (Fig. 2B and C). In both HEK293T and HeLa
cells, endogenous FAM123A was detected within endogenous EB1 immunopurified protein
complexes (Fig. 2D and E). Confocal Z-series images of HeLa cells expressing EGFP-
FAM123A and immunofluorescently labeled for endogenous EB1 demonstrated basal co-
localization of these proteins with increased intensity at the microtubule distal ends towards
the leading edge (Fig. 2F).
APC directly interacts with EB1 and FAM123A. To determine whether FAM123A
indirectly binds EB1 through APC (21), we purified FAM123A from cells transfected with
siRNAs targeting either APC or EB1 and found that FAM123A interacts with EB1 in the
absence of APC, and similarly interacts with APC after silencing of EB1 (Fig. 3A). These
results suggest that FAM123A independently binds APC and EB1. Although WTX
associates with APC, it did not affinity purify with EB1 (Fig. 1C). To map the domains of
FAM123A that interacted with APC and EB1, we generated a series of FAM123A deletion
mutants based on homology within the WTX family and on secondary structure prediction
for FAM123A (http://robetta.bakerlab.org/). Affinity purification of full length FAM123A
protein or the truncated fragments from cells expressing EB1 or APC indicated that
FAM123A interacted with EB1 through its extreme C-terminus, specifically amino acids
457-552 (Fig. 3B) and with APC through an N-terminal domain comprising amino acids
261-349 (Fig. 3C). Additionally, FAM123A interacted with βTrCP2 through a C-terminal
region encompassing residues 261-470, which overlaps with the APC binding domain (Fig.
3D and S2). These results demonstrate that FAM123A independently interacts with EB1 and
APC through non-overlapping domains.
FAM123A interacts with EB proteins through the EB binding motif “Ser-x-Ile-Pro”
Many plus-end tracking proteins contain a characteristic EB-binding motif, which is defined
by a Ser-x-Ile-Pro (SxIP) consensus (Fig. 4A) (22), and which enables direct binding to EB1
and EB3 and consequently localization to the growing microtubule plus-end. We found a
SKIP487-490 and a TKIP518-521 motif within FAM123A, both of which are in the EB1
binding region identified by domain-mapping (Fig. 3B). To determine if the SKIP487-490
motif is required for binding to EB1 and EB3 we created a mutant in which Ile489 and
Pro490 residues were changed to alanine (FAM123A-IPAA) (Fig. 4A). Affinity purification
and Western blot analysis revealed that in contrast to wild-type FAM123A, the IPAA
mutant did not pull-down EB1 or EB3 (Fig. 4B and 4C). These results demonstrate that the
SKIP487-490 motif in FAM123A is necessary for association with EB1 and EB3; whether the
TKIP518-521 motif contributes to binding in the presence of the SKIP487-490 motif remains to
be tested.
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Many plus-end tracking proteins containing the “SxIP motif” bind a coiled coil domain
within the C-terminus of EBs, referred to as the EBH domain (17, 22). To determine if
FAM123A also binds to the EBH domain of EB1, we generated two EB1 deletion constructs
that encoded the N-terminal microtubule binding domain (AA 1-135) or the C-terminal EBH
domain (AA 136-268). Affinity purification of FAM123A from cells co-expressing these
EB1 truncations revealed an association between FAM123A and the EBH domain of EB1
(Fig. 4D). Thus, FAM123A interacts with the C-terminal region of EB1 through the
consensus EB1 binding motif “SxIP”.
The SxIP motif targets functionally and structurally unrelated plus-end tracking proteins to
growing microtubule ends in an EB dependent manner (22). To determine if FAM123A
microtubule localization and plus-end tracking require EB association, we compared the
protein distribution and dynamics of FAM123A and FAM123A-IPAA by live cell imaging
(Fig. 4E and movie S4 and movie S5). Wild-type FAM123A coated the distal ends of the
microtubule and co-tracked with EB3 in the cell body (movie S4). In contrast, FAM123A-
IPAA exhibited decreased EB3-associated plus-end tip tracking and microtubule decoration,
coating very few microtubule stretches at the cell periphery (movie S5). A C-terminal
fragment of FAM123A which contains the SKIP487-490 EB-interaction motif did not
decorate the microtubule lattice, but rather behaved as a classic plus-end microtubule
binding protein showing robust EB3-associated tip tracking (Fig. S3 and movie S6).
Mutation of the SKIP487-490 motif completely abolished microtubule co-localization and
EB3-associated tip tracking (Fig. S3 and movie S7).
Despite the autonomous microtubule binding capability of EB proteins in vitro, FAM123A
could influence EB1 loading or distribution on microtubules ex vivo. However, depletion of
FAM123A in HeLa cells did not affect the subcellular distribution of endogenous EB1 (Fig.
4F). To complement the loss-of-function approach, we localized EB1 in cells stably over-
expressing FAM123A (Fig. S4). Forced expression of FAM123A, but not FAM123A-IPAA,
re-localized EB1 to the microtubule lattice at the bottom of the cell and to the plasma
membrane more apically. Although consistent with its ability to bind EB1, it remains to be
seen whether its re-distribution following FAM123A over-expression occurs normally.
Together these data demonstrate that: (i) FAM123A is a microtubule associated protein with
EB-dependent plus-end tip tracking capabilities, (ii) FAM123A binds EB proteins through
the SKIP487-490 motif, (iii) FAM123A predominantly decorates the microtubule lattice at the
cell periphery in a largely EB-dependent fashion, and (iv) FAM123A silencing does not
affect EB1 subcellular localization.
EB-protein association is not required for FAM123A regulation of Wnt signaling
Of the three FAM123 family members, only FAM123A contains a SxIP motif, which is
consistent with the lack of association between WTX and EB1 (Fig. 1A and 1C). Given this
unique protein interaction within the FAM123 family, we predicted that the EB1 association
would be dispensable for the common functions of WTX and FAM123A, such as regulation
of β-catenin dependent WNT signaling (5, 7, 11). Indeed, siRNA-based knockdown of
FAM123A or WTX increased the activity of a β-catenin reporter gene (Fig. S5A). In a gain-
of-function approach, over-expression of FAM123A or FAM123A-IPAA reduced WNT3A-
dependent reporter activation in a concentration dependent manner (Fig. S5B and C). These
data suggest that the ability of FAM123A to modulate the Wnt/β-catenin pathway is
independent of its interaction with EB1 and microtubules.
FAM123A controls microtubule organization and growth rates
Because FAM123A bound EB proteins and moved on microtubules, we tested whether its
loss affected microtubule organization and dynamics. siRNA-mediated silencing of
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FAM123A in HeLa cells induced disorganization of the microtubule network with
excessively curved microtubules and increased microtubule density (Fig. 5A and B). In
contrast, siRNA mediated silencing of WTX yielded a distinct microtubule organization
(Fig. 5A). We used total internal reflective fluorescence (TIRF) microscopy to image GFP-
tagged EB3 in siRNA-transfected HeLa cells and found that FAM123A promotes
microtubule growth within the cell body, because cells lacking FAM123A had significantly
slower microtubule polymerization (Fig. 5C and D). In contrast, in the absence of
FAM123A microtubules demonstrated less dynamic movement near F-actin bundles,
particularly near adhesion complexes (Fig. 5D). Thus, FAM123A regulates microtubule
dynamics and the overall organization of the microtubule network.
FAM123A inhibits actin contractility by suppressing the GEF-H1-RhoA-ROCK-MLC
pathway
In addition to the altered microtubule organization, we noticed that FAM123A-depleted
cells had phase dark cortical membranes (Fig. 6A). These observations and the increase in
cortical F-actin detected by TIRF microscopy (Fig. 5D) suggested involvement of the
signaling pathway that mediates crosstalk between the microtubule and actomyosin
cytoskeletal networks (15, 23). Specifically, microtubule depolymerization induces actin
stress fiber formation and cell contractility through activation of the Rho-specific exchange
factor GEF-H1, which subsequently activates RhoA, Rho kinase (ROCK) and myosin light
chain (MLC) (Fig. 6B)(24, 25). In FAM123A-silenced HeLa cells, thick and short actin
stress fibers were disposed in a non-parallel arrangement and microtubule depolymerization
induced by nocodazole treatment resulted in several morphological changes, including thick
bundles of contracted actin stress fibers frequently localized at the cell center, kidney-shaped
nuclei shifted to the cell periphery, and cytoplasmic pools of free tubulin confined to a small
area close to the nucleus or near the cell center (or both) (Fig. 6D). Thus, FAM123A-
depleted cells display an altered microtubule network and increased actomyosin contractility
that is exacerbated with nocodazole treatment.
We employed multiple experimental approaches to determine whether FAM123A induced
actomyosin contractility requires the GEF-H1-RhoA-ROCK-MLC2 pathway. First,
treatment of cells with the ROCK inhibitor Y-27632 (26) abolished actin stress fiber
formation and cell contractility induced by FAM123A knockdown (Fig. 6C). Second,
siRNAs targeting GEF-H1 reversed the actomyosin contractility induced by FAM123A
depletion, but did not rescue the disordered microtubule phenotype induced by FAM123A
silencing (Fig. 6D). By blinded quantitation, 78% of FAM123A depleted cells were scored
as displaying increased actomyosin contractility; in the absence of GEF-H1, this was
reduced to 38% of cells (Fig. 6E). As was previously reported, silencing of GEF-H1 resulted
in decreased actin bundling (Fig. S6)(24). Third, activation of RhoA was higher in cells
depleted of FAM123A than in control siRNA-transfected cells, an effect that required GEF-
H1 (Fig. 6F). Fourth, phosphorylation of myosin was increased in FAM123A silenced cells,
but not in cells in which both FAM123A and GEF-H1 were depleted (Fig. 6G-I). By
immunofluorescence, phosphorylated MLC localized primarily to stress fibers near the cell
periphery following FAM123A loss (Fig. 6I), compared to the more uniform distribution
seen in control siRNA transfected cells. Finally, we employed a serum response factor
(SRF) transcriptional activity assay as an indirect readout for RhoA activity and actomyosin
contractility (27). FAM123A-silencing induced SRF reporter activity in a GEF-H1-
dependent fashion (Fig. 6J). FAM123A overexpression repressed SRF-mediated
transcription induced by both nocodazole and GEF-H1 over-expression (Fig. 6K). Together,
these data demonstrate that FAM123A decreases actin contractility by inhibiting the GEF-
H1 pathway and that epistatically, FAM123A functions upstream of GEF-H1.
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Because cellular morphology and cytoskeletal organization are particularly sensitive to
transfection and siRNA-based off target effects, we further validated the specificity of the
FAM123A phenotype. HeLa cells expressing one of two siRNAs that targeted the 3′UTR of
FAM123A (Fig. S7A) showed an exacerbated actomyosin contractility phenotype following
nocodazole treatment, similar to the open reading frame-directed FAM123A#1 and #2
siRNAs. This phenotype was rescued by forced expression of a FAM123A-GFP fusion
protein (Fig. S7B). Together these data confirm that FAM123A decreases actomyosin
contractility.
FAM123A binds to and inhibits GEF-H1 activity
Proteomic analysis of the FAM123A protein complex identified GEF-H1 as a potential
interacting protein, suggesting a molecular mechanism by which FAM123A controls
actomyosin contractility (Fig. 1A). First, we confirmed the GEF-H1-FAM123A interaction
by Western blot analysis of affinity-purified FAM123A protein complexes or
immunopurified GEF-H1 protein complexes (Fig. 7A and B). Endogenous GEF-H1 was
detected in affinity purified FAM123A protein complexes (Fig. 7A), and FAM123A
immunopurified with endogenous GEF-H1 (Fig. 7B). The FAM123A-IPAA mutant, which
lacks the ability to bind EB proteins, also associated with GEF-H1 (Fig. 7A and B).
Additionally, we detected the endogenous forms of the microtubule associated proteins
CLASP2 and MARK2 in FAM123A affinity purified protein complexes, as was suggested
by the FAM123A proteomic analyses (Fig. 7A).
As a first test of the functional relationship between FAM132 and GEF-H1, we assessed the
activation status of GEF-H1 in FAM123A-depleted cells by purifying active GEF-H1 with a
nucleotide-free mutant of RhoA, RhoA-G17A coupled to GST (28). Western blot analysis of
RhoA-G17A pull-downs revealed a significant increase in active GEF-H1following
FAM123 Adepletion.(Fig. 7C). We attempted to examine the subcellular localization of
GEF-H1 after FAM123A over-expression or knockdown; however, we were unable to
visualize microtubule-localization of GEF-H1 using various commercially available
antibodies and fixation techniques. We reasoned that an effect of FAM123A on GEF-H1
activity could be indirectly assessed by global interrogation of the GEF-H1 protein
interaction network. For this approach, we employed SILAC (stable isotope labeling with
amino acids in cell culture)-based quantitative proteomics of immunopurified endogenous
GEF-H1 protein complexes from parental cells or cells over-expressing FAM123A.
Averaging the SILAC ratios from biological replicates identified GEF-H1 protein
interactions that were increased by FAM123A expression, such as the association between
GEF-H1 and DSTN, an F-actin depolymerizing protein (29, 30), and those that were
decreased by FAM123A expression, such as the association between GEF-H1 and SLK, a
kinase involved in actin and microtubule organization (31-33). Together, these data
demonstrate that FAM123A controls GEF-H1 activity and GEF-H1 protein-protein
interactions.
FAM123A regulates cell adhesion and cell migration
Actin stress fibers and focal adhesions are physically and functionally tethered; increases in
cellular contractility or application of external mechanical force induces simultaneous
growth of focal adhesions and the attached actin stress fibers (34, 35). To determine if
actomyosin contractility induced by FAM123A loss impacted focal adhesions, we visualized
vinculin as a marker of focal adhesions (Fig. 8A). Consistent with higher contractility,
FAM123A depleted cells had larger adhesions than control cells (Fig. 8A). To assess cell
adhesion and spreading assay, we performed real time quantitation of electrical impedance
during cell spreading, which revealed no effect of FAM123A silencing during the early
stages of cell attachment and spreading (Fig. 8B). However, FAM123A depleted cells had
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higher impedance values than control cells after the first hour of cell plating, indicating
increased adhesion (Fig. 8C), a phenotype that required GEF-H1 (Fig. 8B and C). We also
examined the formation of adhesion complexes by immunostaining during cell spreading
(Fig. 8D and S8). Consistent with the results from the cell spreading assay, FAM123A
depleted and control cells showed phenotypically similar formation of adhesion and actin
stress fibers in the early stages of cell spreading. However, after the first hour, the adhesions
in FAM123A depleted cells were larger and had thicker actin stress fibers, effects that were
GEF-H1 dependent because cells depleted of both FAM123A and GEF-H1 or GEF-H1
alone resembled the control siRNA transfected cells. Given these cytoskeletal and adhesion
phenotypes, we tested whether FAM123A silencing impacted cell migration. HeLa cells
transfected with either control or FAM123A siRNAs were plated to confluency, scratched
and imaged by live cell microscopy. Compared to control siRNA transfected cells,
FAM123A depletion resulted in a 20% decrease in cell migration, which may result from
increased adhesion (Fig. 8E).
Discussion
We performed unbiased protein-protein interaction screens to discover new functions for
members of the FAM123 protein family. Here, we have characterized a ‘family-unique’
physical and functional relationship between FAM123A and the microtubule and
actomyosin cytoskeletal networks. We found that FAM123A binds EB proteins and interacts
with dynamic microtubules through its SKIP487-490 motif. FAM123A knockdown resulted
in compartment-specific effects on microtubule dynamics, a globally disorganized
microtubule network, increased GEF-H1 activity, increased actomyosin contractility, and
increased cell adhesion and decreased cell migration.
Members of the FAM123 gene family control β-catenin dependent WNT signaling
FAM123A inhibits β-catenin-dependent WNT signaling (11). Our data both confirm these
findings and provide additional mechanistic insight. First, comparative protein-protein
interaction studies of WTX and FAM123A revealed a robust association between β-catenin
and WTX, but not with FAM123A. Although a low affinity or transient interaction between
FAM123A and β-catenin may occur, we interpret our data to suggest that association with
β-catenin is not required for regulation of WNT signaling by WTX (or FAM123A).
Consistent with this notion, the REA repeats in WTX that are responsible for mediating
direct interaction with β-catenin are found only in mammalian orthologues of WTX,
although WTX inhibits WNT signaling in Zebrafish and Xenopus(7). Based on our findings,
it is likely that WTX and FAM123A inhibit WNT signaling through interactions with APC
or βTrCP1/2 (or both), which associate with both WTX and FAM123A.
Our data demonstrate that the FAM123A-EB interaction is dispensable for WNT regulation,
at least with respect to non-polarized cells grown in two dimensions. In contrast to WTX
which is uniformly distributed across human tissues, FAM123A is largely restricted to
neuronal tissues(9). These disparities in distribution may provide an explanation as to why
the ability to control cytoskeletal dynamics is specific to FAM123A, which may have
evolved to remodel the cytoskeleton during neuronal migration(11). Because the FAM123C
protein interaction network did not share common protein associations with FAM123A or
WTX, our data suggest that FAM123C lacks regulatory functions over WNT signaling,
although this remains to be formally demonstrated.
FAM123A tracks growing microtubules
Plus-end tracking proteins comprise a structurally and functionally diverse group of
microtubule-associated proteins that accumulate at the ends of growing microtubules (15,
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17, 19, 36). Many plus-end tracking proteins have a conserved SxIP motif that directly
associates with EB proteins and thus mediates localization to the microtubule plus-end (22).
In at least two ways, however, our protein dynamic studies also differentiate FAM123A
from other plus-end tracking proteins.
First, unlike EB1 and many plus-end tracking proteins which localize to microtubule tips
throughout the cell body, FAM123A predominantly decorates the distal ends of
microtubules oriented in the direction of cell movement, a polarized distribution also seen
for CLASPs, APC, and CDK5RAP2 (37-40). Through asymmetric distribution to the
leading edge, these plus-end tracking proteins modulate microtubule dynamics and
consequently promote cell polarization and directional migration (41, 42). We found that
FAM123A loss differentially affects microtubule dynamics in different subcellular
compartments (Fig. 5). Therefore, it is possible that FAM123A functions to regulate
spatially-confined microtubule stability, which presumably contributes to the establishment,
maintenance, or modulation of asymmetric cell behavior.
Second, although they bind EB proteins for plus-end tracking, many plus-end tracking
proteins can also directly associate with microtubules. By contrast, FAM123A microtubule
tracking and localization was largely attenuated in the absence of EB-association; one
possibility is that the remaining microtubule localization is due to bridging proteins that
tether the N-terminus of FAM123A to the microtubule, such as APC. Moreover, the
subcellular distribution of full length FAM123A and the C-terminal fragment are
substantially different, although both bind EB proteins and track with assembling
microtubule ends. Whereas the C-terminus co-localizes with EB-comets, full-length
FAM123A exhibits slower microtubule tracking near the cortex, frequently coating the
microtubule lattice. These data suggest that FAM123A may be involved in coupling
assembling microtubules to membrane signaling pathways.
FAM123A regulates microtubule dynamics and organization
Like many other EB-dependent plus-end tracking proteins, we found that FAM123A
depletion results in a disorganized microtubule network. Whereas FAM123A
asymmetrically localized to microtubules in the direction of cell movement, its depletion
affected microtubule architecture throughout the entire cell body. FAM123A depletion
resulted in decreased microtubule polymerization rates within the cell body and less
dynamic and stabilized microtubules in apposition to actin adhesion complexes. Although
untested, it is possible that the decreased microtubule polymerization rates occur secondarily
to the increased cortical stability because of reprogramming overall tubulin homeostasis. For
example, decreases in free tubulin dimers as a result of increased stability in some
microtubules may result in global effects on microtubule dynamics (43). It also remains
possible that actomyosin contractility induced by FAM123A silencing functions in a feed-
forward loop to globally influence microtubule dynamics (44). Although our data do not
provide an exact mechanism, we propose that FAM123A may control microtubule dynamics
by regulating cortical capture through the tethering of microtubules to the plasma
membrane. That is, FAM123A complexes with several plus-end tracking proteins thought to
stabilize microtubules at the leading edge, such as EB1, EB3, CLASPs, APC and ACF7
(15). It is possible that in association with these plus-end tracking proteins, FAM123A
asymmetrically tracks microtubules in the direction of cell movement and promotes both
cortical microtubule stabilization and polarized cargo delivery to the cortical membrane.
Because WTX and FAM123A bind phospholipids and localize predominantly to the
cytoplasmic membrane, an elaboration on this model might have FAM123A ‘jumping’ off
of microtubules onto a phospholipid landing pad, perhaps delivering its associated proteins,
such as GEF-H1 and APC, to the leading edge. In agreement with this model, FAM123A
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recruits APC to the plasma membrane and drives EB1 to the membrane when over-
expressed (Fig. S4)(6, 11).
FAM123A inhibits actomyosin contractility, thereby regulating adhesion and cell migration
Our data suggest that FAM123A binds to and inhibits GEF-H1, a guanine nucleotide
exchange factor that localizes to microtubules, is activated by microtubule de-
polymerization and activates RhoA-dependent actomyosin contraction (24, 25). We show
that FAM123A depletion results in GEF-H1-dependent increased actomyosin contractility,
enlarged focal adhesions, increased cellular adhesion and decreased cell migration (Fig. 8).
These observations demonstrate that FAM123A is similar to PAK1, PAK4, calpain-6,
MARK2 and ERK, all of which regulate GEF-H1 to control spatiotemporal regulation of the
actin cytoskeleton (45-54). That said, several important questions remain regarding the
precise molecular mechanism by which FAM123A regulates GEF-H1.
First, our data demonstrate that FAM123A is epistatically upstream of GEF-H1 with respect
to RhoA, ROCK, MLC2, actomyosin contractility and cell adhesion, but not to microtubule
organization (Fig. 6). Therefore, actomyosin contractility likely underlies the FAM123A-
dependent cell adhesion phenotype, rather than altered microtubule dynamics. Given the
limitations of interpreting cause and effect from siRNA-based experiments, additional
studies are needed to more precisely define the role of FAM123A in microtubule dynamics
and to understand how that effect is communicated through GEF-H1 to the actomyosin
network. Second, as mentioned, the precise mechanism by which FAM123A inhibits GEF-
H1 remains to be established. Although we show that ectopic FAM123A binds endogenous
GEF-H1 (and vice-versa), it remains to be determined if the endogenous proteins associate.
Moreover, we were unable to demonstrate GEF-H1 subcellular co-localization with
FAM123A. Third, we found that FAM123A inhibits GEF-H1 in the presence and absence of
microtubules. Specifically, the IPAA mutant form of FAM123A which does not bind
microtubules associates with GEF-H1 and FAM123A knockdown exacerbates actin
contraction in the absence of microtubules (Fig. 8 and Fig, 6, respectively). These data
suggest that FAM123A functionally impacts GEF-H1 independently of microtubule
polymerization status, similar to TNFα-mediated GEF-H1 activation in tubular epithelia
(48, 49). Finally, we found that FAM123A altered the GEF-H1 protein interaction network,
which we interpret as further corroborative evidence that FAM123A controls GEF-H1
activity or subcellular localization. The biological implications of these GEF-H1 interactions
and their control by FAM123A await further study.
In summary, we found using comparative proteomic analyses of the FAM123 family that
FAM123A associates with numerous microtubule-binding proteins. Subsequent protein
dynamic studies and functional interrogation revealed that FAM123A controls microtubule




FAM123A isoform 2 cDNA was obtained by PCR amplification from clone BCO32653
(OPEN Biosystems). The mutant FAM123A-IPAA (Ile489-Pro490 mutagenized to Ala489-
Ala490) was created by standard PCR-based mutagenesis. The WTX constructs were
previously described (5). The EB3-pEGFPN1 and EB3-RFP constructs were provided by A.
Akhmanova, Erasmus Medical Center, Rotterdam, Netherlands. The EB1-pEGFPN1
construct was provided by L. Cassimeris, Lehigh University, Bethelehm, PA. EB1-
pEGFPN2 and the deletions were obtained amplifying EB1 by PCR from pEGFPN1-EB1
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construct. The mCherry-tubulin plasmid was made by replacing GFP at the BsrGI and
BamHI sites in pEGFP-Tub with mCherry. The β-catenin–activated Firefly reporter (pBAR)
and pcDNA3.1-Flag-APC (AA1-1060) were previously described (5). The SRF-RE reporter
was obtained from Promega (pGL4.34[luc2P/SRF-RE/Hygro]; Madison, WI). GFP-GEF-H1
was kindly provided by Rafael Garcia-Mata, UNC-Chapel Hill.
Reagents
Wnt3A and control conditioned medium was produced in mouse L cells according to the
ATCC protocol. Nocodazole and Y-27632 were purchased from Sigma (M1404 and Y0503,
Sigma-Aldrich Corporation, St. Louis, MO).
Tissue culture, transfections and reporter assays
All cells were grown in DMEM supplemented with 10% FBS and 1% penicillin/
streptomycin, in a 37 °C humidified incubator with 5% CO2. Transient transfections of
siRNAs were performed with Lipofectamine RNAiMAX, as directed by the manufacturer
(Invitrogen Carlsbad, CA). All siRNAs were used at a final concentration of 20 nM and for
72 hours unless otherwise stated. siRNAs targeting human forms of WTX (siRNA#1 and
#2), APC, axin1/2 and β-catenin have been previously published (5). The following siRNAs
were employed: Control: Stealth M2 from Invitrogen; EB1, AAG UGA AAU UCC AAG
CUA AGC (42); FAM123A siRNA#1, GCC GGC UCU GUC UAA AAA G[dT][dT];
FAM123A siRNA#2, GAG AUA UUA UUG CAG ACC AAG AGG; FAM123A siRNA#3,
CCU ACG UUC AGU UGU UAG AUA UGC A, FAM123A siRNA#4, CCU CUC AAG
AUA AGU CCC UGA GAA U; GEF-H1 siRNA#1, AGC AGG CCA CGG AAC UGG
CAU UAC U; GEF-H1 siRNA#2, UCC AUA CAC GCU UCC UCA GCC AGC U; WTX
siRNA#3, AAA GGC AGU CAU CUC CAG GUG GAG A. All siRNAs were synthesized
by Invitrogen as Stealths, except for EB1 and FAM123A#1. Expression constructs were
transiently transfected into HEK293T cells with Lipofectamine 2000 (Invitrogen Carlsbad,
CA) or into HeLa cells with Fugene6-HD (Roche, Indianapolis, IN), as directed by the
manufacturer. For gain-of-function reporter assays, cells were seeded in 48-well plates prior
to transfection with a Firefly luciferase reporter, Renilla luciferase control reporter and
effector plasmids. Cells stably engineered with these reporters were employed for the loss-
of-function experiments. Luciferase activity was quantitated with the Dual Glow Luciferase
Assay System (Promega, Madion, WI).
Affinity purification and mass spectrometry
Tandem affinity purification of FAM123A (isoform2) was performed as previously
described (55, 56), with minor modifications. Protein complexes were eluted from the
streptavidin beads with 5 mM biotin in the absence of TEV protease. 0.1% PPS Silent
Surfactant (Protein Discovery, San Diego, CA) was included in the final elution from the
calmodulin beads. Prior to mass spectrometry, PPS was acid cleaved at 37°C for 30 min.
Flag-based AP/MS of FAM123C was performed in triplicate as previously described (57).
Quantitative IP/MS of endogenous GEF-H1 was performed in duplicate via SILAC (K6/
R10) labeling. Briefly, ∼150mg of protein lysate from the following HEK293T-derived cell
lines were compared at low confluency: parental cells (light) and Flag-FAM123A (heavy) or
GFP (light) and HA-FAM123A (heavy). Cells were lysed in 50 mM Hepes-NaOH at pH 8.0,
150 mMNaCl, 10% glycerol, 0.1% NP40, 2 mM EDTA, 2 mM DTT, protease and
phosphatase inhibitor cocktails (Roche, Indianapolis, IN) and subjected to
immunoprecipitation with 10μg GEF-H1 antibody (A301-929A, Bethyl Labs, Montgomery,
TX). Following an on-beads digestion with FASP Protein Digestion Kit (Protein Discovery,
San Diego, CA), tryptic peptides were cleaned up by C18 Spin Column (Thermo Scientific,
Waltham, MA), then separated by reverse phase nano-HPLC using a nanoAquity UPLC
system (Waters Corp, Milford, MA). Peptides were first trapped in a 2 cm trapping column
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(75 μm ID, Michrom Magic C18 beads of 5.0 μM particle size, 200 Å pore size) and then
separated on a self-packed 25 cm column (75 μm ID, Michrom Magic C18 beads of 3.0 μM
particle size, 100 Å pore size) at room temperature. The flow rate was 200 nl/min over a
gradient of 1% buffer B (0.1% formic acid in acetonitrile) to 30% buffer B in 180 min. Then
a following wash raised buffer B to 70%. The identity of the eluted peptides was determined
with an in-line LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific, Waltham, MA).
The ion source was operated at 2.0-2.4 kV with ion transfer tube temperature set at 275 °C.
Full MS scan (300-2000 m/z) was acquired in Orbitrap with 60,000 resolution setting, data-
dependent MS2 spectra were acquired in LTQ by collision induced dissociation (CID) using
the 20 most intense ions. Precursor ions were selected based on charge states (1, 2 or 3) and
intensity thresholds (above 2000) from the full scan, dynamic exclusion (one repeat during
30-s, a 60-s exclusion time window) was also taken into account. The polysiloxane lock
mass of 445.120030 was used throughout spectral acquisition.
Protein identification and quantification
All raw data were converted to mzXML format before a search of the resultant spectra using
Sorcerer™-SEQUEST® (build 4.0.4, Sage N Research, Milpitas, CA) and the
Transproteomic Pipeline (TPP v4.3.1). Data were searched against the human UniProtKB/
Swiss-Prot sequence database (Release 2011_08) supplemented with common contaminants,
such as porcine (Swiss-Prot P00761) and bovine (P00760) trypsin, and further concatenated
with its reversed copy as a decoy (40, 494 total sequences). Search parameters used were a
precursor mass between 400 and 4500 amu, up to 2 missed cleavages, precursor-ion
tolerance of 3 amu, accurate mass binning within Peptide Prophet (58), semi-tryptic
digestion, a static carbamidomethyl cysteine modification, variable methionine oxidation,
and additional variable modifications of R10 and K6 for SILAC experiments. SILAC ratios
were calculated using TPP's XPRESS (59) and protein abundance ratios were first
normalized by the bait's ratio, then combined from replicate experiments by taking a
weighted average using the number of quantified spectra for the protein in each replicate.
False discovery rates (FDR) were determined by ProteinProphet (58) and minimum protein
probability cutoffs resulting in a 1% FDR were selected individually for each experiment.
Further filtering of identified proteins was accomplished using the following criteria: at least
2 unique peptides were identified for the protein in each of at least 2 (out of 4) WTX
experiments, at least 2 (out of 3) for proteins in FAM123C experiments, 2 (out of 2) for
ARHGEF2, and 2 (out of 3) for FAM123A. Common contaminants were removed at the
authors' discretion based on previous experiments, such as keratins, ribosomal, and DEAD
box proteins. Unfiltered data are provided as Table S1 and may be downloaded from





PeptideProphet/ProteinProphet results for each AP-MS experiment were stored in a local
Prohits database (60). Prohits performed the mapping of UniProtKB accession identifiers to
Entrez Gene IDs. These results were then imported into Cytoscape v2.8.2 (61) for network
visualization. Gene Ontology annotations were imported from NCBI Entrez Gene through
Cytoscape. Known protein-protein interactions were extracted from the following databases:
BIND, BioGRID, DIP, HPRD, IntAct, MINT, and Reactome – downloaded on 08/15/2010.
Affinity pull-downs, Immunoprecipitation, and Western blotting
In all biochemical experiments cells were lysed in a buffer containing 50 mM Tris-HCl at
pH 8.0, 150 mM NaCl, 10% glycerol, 1% TritonX-100, 2 mM EDTA, protease and
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phosphatase inhibitor cocktails (Roche). For streptavidin affinity purification cleared lysates
were incubated 1 hour with streptavidin resin (GE Healthcare, Piscataway, NJ) before
washing and eluting. Immunoprecipitation of endogenous GEF-H1 was performed using
antibodies anti-GEF-H1 (A301-929A, Bethyl Labs, Montgomery, TX). Detection of proteins
by Western blot was performed using the following antibodies: anti-FLAG M2 monoclonal
(Sigma-Aldrich Corporation, St. Louis, MO); anti-HA polyclonal (1867423; Roche,
Indianapolis, IN; anti-GFP polyclonal (ab290, Abcam, Cambridge, MA); anti-β-catenin
polyclonal (9562; Cell Signaling Technology, Danvers, MA); anti-βTrCP1 monoclonal
(37-3400, Invitrogen Carlsbad, CA); anti β-tubulin monoclonal (T7816; Sigma-Aldrich
Corporation, St. Louis, MO); anti-GEF-H1 (A301-928A, Bethyl Labs, Montgomery, TX);
anti-MARK2 (Roche, Indianapolis, IN); anti-CLASP2 (A302-155A, Bethyl Labs,
Montgomery, TX); anti-APC polyclonal (A300-180A, A300-981A, Bethyl Labs,
Montgomery, TX); and anti-EB1 monoclonal (610534, BD Transduction Laboratories,
Franklin Lakes, NJ); anti-MLC2 (3672, Cell Signaling Technology, Danvers, MA); anti-p-
MLC2 Ser19 (#3671, Cell Signaling Technology, Danvers, MA). To detect endogenous
FAM123A, a custom monoclonal antibody was produced (Abmart, Shanghai, China).
For phospho-MLC detection, Hela cells were transfected with siRNA at 10nM for 48h. Cells
were lysed in the well with UPX sample buffer from Protein Discovery (San Diego, CA)
supplemented with protease and phosphatase inhibitors. Samples were boiled for 3 min
before addition of 4× sample buffer and sonication. Proteins were detected by Western blot
and quantified using Odyssey Imager and Software by LiCor Biosciences (Lincoln, NE).
Immunofluorescence
For immunofluorescence, HeLa sarcoma cells were plated on 10ug/ml fibronectin-coated
coverslips in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal
bovine serum and allowed to attach and spread. Cells were fixed in 4% paraformaldehyde
(PFA, Electron Microscopy Sciences, Hatfield, PA) in cytoskeletal buffer (CS; 5 mM
PIPES, pH 6, 137 mM NaCl, 5 mM KCl, 1.1 mM Na2HPO4, 0.4 mM KH2PO4, 0.4 mM
MgCl2, 0.4 mM NaHCO3, 2 mM EGTA, 50mM glucose) for 15 min, and permeabilized
with 0.1% Triton in phosphate buffer saline (PBS) for 5 min. After blocking in 1% bovine
serum albumin (BSA)/PBS for 1hour, cells were incubated with primary antibodies at 4C,
overnight, followed by incubation with appropriate secondary antibodies RRX-conjugated-
donkey anti-mouse IgG and FITC-conjugated-donkey anti-mouse IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA) at room temperature for 1 hour. For
staining of endogenous EB1, cells were fixed in methanol at -20C for 5 min. Staining of
proteins was performed using the following antibodies: monoclonal anti-α-tubulin (clone
DM1A, T9026, Sigma-Aldrich Corporation, St. Louis, MO), monoclonal anti-vinculin
(clone nVIN-1, V9131, Sigma-Aldrich Corporation, St. Louis, MO) and anti-EB1
monoclonal (610534, BD Transduction Laboratories, Franklin Lakes, NJ). Actin was stained
using Alexa Fluor 647-phalloidin or Alexa Fluor 594-phalloidin (Invitrogen Carlsbad, CA).
Coverslips were mounted to slides using the Prolong Gold antifade reagent (Invitrogen
Carlsbad, CA). Staining was analyzed using an Olympus IX 81-ZDC Inverted Fluorescence
Microscope (Olympus Corporation of the Americas, Center Valley, PA) equipped with a
60X/1.42 Oil PlanApo objective lenses and a Hamamatsu C10600-10B camera (OrcaR2,
Hamamatsu Photonics LTD, Japan).
For subcellular localization of FAM123A, HeLa cells were grown on 18-mm glass
coverslips coated with Poly-L-Lysine (Sigma-Aldrich Corporation, St. Louis, MO) and co-
transfected with EGFP-FAM123A and cherry-tubulin. Cells were in fixed in 1%
paraformaldehyde in pure -20°C Methanol for 2 min and mounted using Prolog antifade
gold with DAPI (Invitrogen Carlsbad, CA). The imaging was performed on a Deltavision
deconvolution microscope (Applied Precision, Issaquah WA). To co-stain FAM123A-GFP
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and EB1, cells were fixed similarly and EB1 was stained with anti-EB1antibody (BD
Transduction Laboratories, Franklin Lakes, NJ), followed by incubation with Donkey anti-
mouse secondary (Jackson ImmunoResearch Laboratories, West Grove, PA). Fixed cells
were imaged with a complete Z-series in 0.2 micron sections, deconvolved and projected
using Adobe Photoshop CS and Image J software.
For comparing the distribution of FAM123A family members, HEK293T transiently
expressing fluorescent-tagged proteins were plated on fibronectin coated coverslips, fixed
and mounted as described above and imaged using a Zeiss LSM5 Pascal Confocal Laser
Scanning Microscope equipped with a 63X/1.42 Oil PlanApo objective lenses.
Live cell imaging
For low resolution imaging analysis, HT1080 sarcoma cells were plated onto 5ug/ml
fibronectin-coated Mattek dishes (Mattek Corporation, Ashland, MA) in Dulbecco's
modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and allowed
to attach and spread. Cells were transfected with venus-FAM123A or venus-WTX using
Fugene HD (Promega, Madison, WI) according to manufacturer's instructions. Cells were
imaged the next day in contrast phase and GFP fluorescence on a Nikon Biostation (every 5
min for 10 hours, Nikon, Belmont, CA), with a 20x objective, while at 37°C and 5% CO2.
For dynamic analysis of fluorescence–tagged proteins at higher magnification, HT1080 were
plated onto 5ug/ml fibronectin coated Delta T dishes (Bioptechs, Inc, Butler, PA) in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum
and transfected with EGFP-FAM123A using Fugene HD (Promega, Madison, WI). Next
day cells were imaged at 37°C and 5% CO2, using an Olympus IX 81-ZDC Inverted
Fluorescence Microscope (Olympus Corporation of the Americas, Center Valley, PA)
equipped with a Bioptechs Delta T Open Dish System (Bioptechs, Inc, Butler, PA) with a
heated lid. Time lapse images were captured every 10 seconds, using a heated 60X/1.42 Oil
PlanApo objective lenses and a Hamamatsu C10600-10B camera (OrcaR2, Hamamatsu
Photonics LTD, Japan). Data acquisition was carried out using Volocity (version 5.5.1,
PerkinElmer), and image processing was performed using ImageJ and Adobe Photoshop CS
software.
HeLa cells were transfected with either EGFP-FAM123A, and EGFP-C-terminus
FAM123A or EGFP-C-terminus-FAM123A-IPAA and in some cases co-transfected with
EB3-RFP using a Nucleofector-II (Amaxa Biosystems, Gaithersburg, MD) and plated onto
Poly-D-lysine coated MatTek dishes. After 24 hours of expression the dually-transfected
cells were imaged at 37°C at a rate of 1 frame/5s. on a Deltavision-RT microscope (Applied
Precision, Issaquah, WA). Cells transfected with only one construct (movie S6 and movie
S7) were imaged at a rate of 1 frame/2s.
For microtubule dynamic studies, HeLa cells were transfected with EB3-GFP and RFP-Utr
expressing DNA constructs and plated onto fibronectin coated MatTek filming dishes; RFP-
Utr encodes an RFP-fused calponin homology domain of the utrophin protein (62). The cells
were transfected for 48 hours with either control siRNA or siRNA directed against
FAM123A. The cells were then imaged using a Personal Deltavision (L.W.) custom
outfitted with TIRF light paths and a 60× Olympus TIRF objective. Images were collected at
5 second intervals. Z-projections were made using successive 5-frame intervals for a total of
15 frames. Each 5 frame projection was colored red, green or blue to visualize the
assembling microtubule ends. Using this regime, stationary microtubule ends consisting of
RGB overlap are depicted as white.
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To quantitate cell migration, HeLa cells were transfected with 10 nM siRNA and plated onto
a 12 well plate (4×10e5 cells/well) in complete growth media 48 hours after transfections.
After 12 hours, the monolayer of cells were wounded by manual scratching with a pipet tip,
washed with PBS and placed into complete growth medium. Time lapse phase contrast
images were acquired every 7 min for 18h using an Olympus I×70 Inverted Fluorescence
Microscope, enclosed within an environmental chamber controlling temperature, relative
humidity and CO2, and equipped with a 4× 0.13 Uplan FL PhL lens and a Hamamatasu
ORCA C4742-95 CCD camera. Data was acquired with Velocity (version 5.5.1,
PerkinElmer). To calculate relative migration, the scratch area was determined from movie-
derived images at time zero and at 6 hours. The difference in area between t=0 and t=6 at 3
locations along the scratch for each of the biological triplicate experiments was used to plot
the relative rate of wound closure.
RhoA and GEF-H1 activity assays
Purified GST-RhoA(G17A) was kindly provided Christophe Guilluy and Keith Burridge
(UNC Chapel Hill, USA). Affinity precipitation of exchange factors with the nucleotide-free
RhoA mutant (G17A) was performed as previously described (28). For quantitation,
Western blot data from 6 biological replicate experiments were analyzed by densitometry.
Data were first normalized to a loading control and then to 1 before averaging and plotting.
Paired Students t Test was calculated using raw data. For RhoA activity quantitation, the G-
LISA RhoA Activation Assay Biochem Kit (Cytoskeleton Inc., Denver, CO) was employed.
Specifically, 4×105 Hela cells were plated in 60mM plates. Cells were transfected overnight
with siRNA and allowed to recover in 10% FBS DMEM for 8 hours. Cells were then
washed with PBS and starved in DMEM for 48 hours with 1 media change at 24 hours.
After 1 hour treatment with nocodazole, cells were lysed in 140μl of cell lysis buffer. Plates
were read on Synergy HT microplate reader from Biotek (Winooski, VT).
Cell Adhesion and Spreading assay
Cell adhesion and spreading were measured as changes in impedance using the RT-CES
system (ACEABiosciences Inc. San Diego, CA). The 16-well E-plates were coated with
10μg/ml fibronectin for 1 hour at 37°C. HeLa cells were transfected with 10nM siRNAs and
subjected to cell spreading assay approximately 65 hours after transfection. For
measurements, the same number of cells (4×103) was added to each well. The e-plates
containing HeLas were allowed to incubate at room temperature for 10 min before being
placed on the device station in the incubator for continuous recording of impedance-based
cell index (CI; every 30 seconds, for 3 hours). Additionally, siRNA-transfected cells were
plated on fibronectin coated coverslips, allowed to attach and spread for various periods of
time, fixed and stained for vinculin according to methods described above.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. FAM123A associates with a microtubule enriched protein interaction network and
moves on microtubules
(A) The WTX and FAM123A protein interaction networks as defined by affinity
purification and mass spectrometry. Proteins shown were represented by at least 2 unique
peptides in at least 2 (out of 4) WTX experiments or at least 2 (out of 3) in FAM123A
experiments. DB, database. (B) The FAM123C protein interaction network, as defined by
proteins which were identified by at least 2 independent peptides in at least 2 out of 3
experiments. In (A) and (B), node size and coloring reflects spectral counts and gene
ontology, respectively. (C) Streptavidin affinity purified protein complexes from HEK293T
cells stably expressing SBPHA-GFP, SBPHA-WTX or SBPHA-FAM123A were analyzed
by Western blot for the indicated endogenous proteins (SBP, streptavidin binding peptide;
HA, hemagglutinin). Data represent 2 biological replicates. (D) Images from movies of
HT1080 cells that were transiently transfected with Venus-tagged FAM123A (movie S1) or
WTX (movie S2) constructs. Data are representative of two independent biological
replicates. Scale bar 20μm. (E) HeLa cells were transfected with EGFP-FAM123A and
mCherry-tagged α-tubulin, treated with DMSO or nocadozole (NOC), fixed, and imaged by
deconvolution microscopy. The FAM123A image is representative of five independent
experiments imaged on five different days. Of 65 imaged cells 39 exhibited long
filamentous structures in cells expressing FAM123A-Venus that co-localized with
microtubules. Scale bar 5μm.
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Figure 2. Interaction of FAM123A with EB1
(A) EB1 or anti-mouse immunoprecipitates from HEK293T cells stably expressing SBPHA-
FAM123A were immunoblotted for the indicated proteins. Data represent 4 biological
replicates. (B) Top: FAM123A mRNA quantitation by quantitative PCR of HEK293T cells
transfected with the indicated siRNAs. The mRNA copy number of FAM123A was
normalized to 18S ribosomal RNA. Error bars represent standard deviation in the PCR
reactions. Bottom: Western blot analysis of FAM123A abundance in SBPHA-FAM123A
stable HEK293T cells transfected with the indicated siRNAs. (C) Western blot analysis of
endogenous FAM123A in HEK293T cells transfected with control or FAM123A-specific
siRNA#2. (D) Endogenous EB1 protein complexes from HEK293T cells were
immunoblotted for FAM123A. (E) Endogenous EB1 immunoprecipitates from HeLa cells
were immunoblotted for FAM123A. (F) HeLa cells transfected with EGFP-FAM123A were
fixed, stained for endogenous EB1, and imaged with confocal microscopy. A Z-projection
for all captured 0.2 μM slices and a single 0.2μM slice at the bottom of the cell is shown.
The co-localization of EGFP-FAM123A with EB1 was analyzed in two independent
experiments imaged on two different days. For 20 EGFP-FAM123A cells analyzed, all 20
showed co-localization with EB1. Scale bar 10μm.
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Figure 3. FAM123A binds APC and EB1 through distinct domains
(A) Cells stably expressing SBPHA-FAM123A were transiently transfected with the
indicated siRNAs, lysed, subjected to streptavidin-affinity purification (AP), and Western
blotted. (B-C) HEK293T cells transiently transfected with EB1-EGFP (B) or APC
(AA1-1060) (C) and the indicated SBPHA-FAM123A fragment were lysed, subjected to
streptavidin-affinity purification and Western blotted. Data represent 3 biological replicates.
(D) The protein domain interaction mapping shown in B, C and Figure S2.
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Figure 4. EB1-association is required for FAM123A microtubule localization
(A) Protein sequence alignment of FAM123A and the SxIP domains of various plus-end
tracking proteins. (B-C) Western blot analysis of streptavidin-affinity pull-downs from
HEK293T transfected with EB1-EGFP (B) or EB3-EGFP (C) and the indicated SBPHA-
FAM123A constructs. Data represent 3 biological replicates. (D) Western blot analysis of
streptavidin-affinity pull-downs assay followed by Western blot analysis of SBPHA-
FAM123A cells transfected with EGFP, EB1-EGFP, EGFP-EB1-N or EGFP-EB1-C. Data
represent 2 biological replicates. (E) Images from live cell imaging of HeLa cells expressing
EGFP-FAM123A (movie S4) or EGFP-FAM123A-IPAA (movie S5). The co-localization of
EGFP-FAM123A was compared to EGFP-FAM123A-IPAA in three replicate experiments
imaged on three separate days. For EGFP-FAM123A a total of 37 cells were imaged live in
conjunction with mRFP-EB3. All cells exhibited greater than or equal to 75% localization of
EGFP-FAM123A with mRFP-EB3 in thresholded images. Of 15 EGFP-FAM123A-IPAA
cells, no cell exhibited more than 5% co-localization of EGFP-FAM123A-IPAA with
mRFP-EB3. Scale bar 5μm. (F) HeLa cells transfected with the indicated siRNAs were co-
stained for EB1 and DAPI. EB1 staining is representative of two biological replicate in
which 46 FAM123A depleted cells and 33 control siRNA transfected cells where imaged.
Scale bar 20μm.
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Figure 5. FAM123A depletion results in altered microtubule organization and increased
actomysin contractility
(A) HeLa cells were transfected with the indicated siRNAs and stained with an anti-α-
tubulin antibody. Images are representative of three independent biological replicates. (B)
Plots of fluorescence intensity of α-tubulin staining in cells from panel (A). The integrated
intensity was measured within a 5-μm2 box at 5 μm distance from the cell periphery, in
three different regions per cell for 23 control and FAM123A siRNA transfected cells.(*,
P<0.0001; Welch-corrected t test) (C) Microtubule polymerization rates in siRNA
transfected HeLa cells. 10 microtubules were measured in each cell. 9 cells were analyzed
for each siRNA. (*, P=0.0129; Welch-corrected t test) (D) TIRF movies of siRNA-
transfected HeLa cells expressing EB3-GFP (left) and RFP-Utr (middle). Left column;
RGB-colorized 5 second Z-projections of EB3-GFP-labeled growing microtubule ends.
Growing filaments are labeled either red, green or blue and overlapping stationary
microtubule ends are white. Regions in cells lacking FAM123 where the microtubule ends
are stationary (not assembling) are indicated (white arrows). Middle column; expressed
RFP-Utr shows the filamentous actin near the cell substratum. Right column; a 15 frame (75
sec.) Z-stack of EB3-GFP (green) and RFP-Utr (red) over time. Stationary microtubule ends
(white arrows) are in close apposition to actin bundles at the cell periphery (red open
arrows).
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Figure 6. FAM123A regulates actomyosin contractility through GEF-H1
(A) HeLa cells transfected with siRNAs were imaged by phase-contrast microscopy. Images
represent >3 biological replicates. Cell morphologies were confirmed with three different
FAM123A siRNAs and 2 different WTX siRNAs. Scale bar 50μm. (B) The major signaling
proteins connecting microtubule destabilization to actin contractility. (C) HeLa cells were
transfected with control or FAM123A siRNA. Where indicated, cells were treated with the
indicated drug before co-staining with an anti-α-tubulin antibody, AlexaFluor 647-
conjugated phalloidin and DAPI. Images are representative of three independent biological
replicate experiments. Scale bar 20μm. (D) siRNA-transfected HeLa cells were treated with
nocodazole and co-stained with an anti-α-tubulin antibody, AlexaFluor 647-conjugated
phalloidin and DAPI. Images are representative of 3 biological replicates. (E) Quantification
of cell phenotypes in (D). Samples were scored in a blinded fashion by 3 independent
investigators. n = number of cells scored. (F) siRNA-transfected HeLa cells were serum
starved, treated with nocodazole, and analyzed for RhoA activity (P=0.002, Student's t-test
of biological triplicate experiments) (G) siRNA-transfected HeLa cells were immunoblotted
for the indicated proteins. Data are representative of 5 biological independent experiments.
(H) Total MLC2 and phosphorylation of MLC2 at Ser19 from biological triplicate
experiments were quantitated by LI-COR and plotted, (* P=0.0159; Student's t-test) (I)
siRNA-transfected HeLa cells were stained with p-MLC Ser19 antibody, AlexaFluor 647-
conjugated phalloidin and DAPI. Images are representative of 3 biological replicates (J)
Quantitation of luciferase activity in HeLa cells expressing a SRF Firefly luciferase reporter
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and a CMV-driven Renilla luciferase reporter. Cells were treated with DMSO or
Nocodazole before luciferase quantitation. (K) Quantitation of luciferase activity in HeLa
cells that were transiently transfected with the indicated expression construct(s), SRF firefly
luciferase reporter and a CMV-driven Renilla luciferase reporter. (* P<0.05, Welch's
corrected t-test of biological triplicates).
Siesser et al. Page 26













Figure 7. FAM123A binds to GEF-H1 and regulates its activity
(A) Streptavidin affinity pull-downs from HEK293T cells stably expressing SBPHA tagged
CCDC94, FAM123A or FAM123A-IPAA were immunoblotted for endogenous associated
proteins. (B) Using the HEK293T stable cell lines described in A, endogenous GEF-H1 was
immunoprecipitated and protein complexes were analyzed by Western blot. (C) Active
GEF-H1 was purified from siRNA-transfected HeLa cells by GST- RhoAG17A pulldown and
immunoblotted. Active GEF-H1 and total cellular GEF-H1 was determined by densitometry
(* P<0.05; Paired Student's t-test of 6 biological replicate experiments; error bars represent
standard error). (E) The GEF-H1 protein interaction network, illustrating the FAM123A-
sensitive interactions as determined by quantitative IP/MS. The average SILAC ratios from
biological duplicate experiments are shown below the network.
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Figure 8. FAM123A regulates cell adhesion and migration
(A) siRNA-transfected HeLa cells were fixed and stained with an anti-vinculin antibody,
Alexa Fluor 594-phalloidin and DAPI. Data represent 4 biological replicates. (B) Adhesion
quantification of siRNA-transfected HeLa cells that were subjected to cell attachment with
real-time acquisition of electrode impedance. (C) Histogram of relative impedance index
180 min after cell plating. Error bars reflect standard error across the biological replicates. (*
P=0.005, * P=0.005; Paired Student's t-test; N = biological replicates) (D) siRNA-
transfected HeLa cells were allowed to attach to fibronectin-coated coverslips for the
indicated times before fixation and immunostaining with an anti-vinculin antibody. (E).
HeLa cells transfected with control or FAM123A siRNA were scratch wounded and imaged
over 24h. (* P=0.03 and ** P=0.018 by the Students t-test). N = 3 biological replicates.
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